Senior Management Team

Michael Narachi
President and Chief Executive Officer

Michael A. Narachi has served as our President and Chief Executive Officer and a member of our board of directors since March 2009. Previously, Mr. Narachi served as Chairman, Chief Executive Officer and President of Ren Pharmaceuticals, Inc., a private biotechnology company, from November 2006 to March 2009. From August 2002 to January 2008, Mr. Narachi served as chairman of the board of directors of Naryx Pharma, Inc., a private pharmaceutical company. In 2004, Mr. Narachi retired as an officer and Vice President of Amgen Inc., a leading therapeutics company, where he served as General Manager of Amgen's Anemia Business from 1999 to 2003. Mr. Narachi joined Amgen in 1984 and held various positions throughout the organization including: Product Development Team Leader for NEUPOGEN® Director of Clinical Operations in Thousand Oaks, CA and Cambridge, UK; Vice President of Development and Representative Director for Amgen Japan; Head of Corporate Strategic Planning; Chief Operations Officer of Amgen BioPharma; and Vice President, Licensing and Business Development. He currently serves on the board of directors of Celladon Corporation and Ultragenyx Pharmaceutical, Inc., both are publicly traded biotechnology companies. Mr. Narachi received a B.S. in Biology and an M.A. degree in Biology and Genetics from the University of California at Davis. He received an M.B.A. from the Anderson Graduate School of Management at University of California, Los Angeles. Mr. Narachi also currently serves as the Chair of the Emerging Companies Section Governing Board of BIO, the Biotechnology Industry Organization, and a member of the Board of Directors of PhRMA, the Pharmaceutical Research and Manufacturers of America.

Michael Narachi
Michael Narachi

Senior Management Team

Michael Narachi
President and Chief Executive Officer

Michael A. Narachi has served as our President and Chief Executive Officer and a member of our board of directors since March 2009. Previously, Mr. Narachi served as Chairman, Chief Executive Officer and President of Ren Pharmaceuticals, Inc., a private biotechnology company, from November 2006 to March 2009. From August 2002 to January 2008, Mr. Narachi served as chairman of the board of directors of Naryx Pharma, Inc., a private pharmaceutical company. In 2004, Mr. Narachi retired as an officer and Vice President of Amgen Inc., a leading therapeutics company, where he served as General Manager of Amgen's Anemia Business from 1999 to 2003. Mr. Narachi joined Amgen in 1984 and held various positions throughout the organization including: Product Development Team Leader for NEUPOGEN® Director of Clinical Operations in Thousand Oaks, CA and Cambridge, UK; Vice President of Development and Representative Director for Amgen Japan; Head of Corporate Strategic Planning; Chief Operations Officer of Amgen BioPharma; and Vice President, Licensing and Business Development. He currently serves on the board of directors of Celladon Corporation and Ultragenyx Pharmaceutical, Inc., both are publicly traded biotechnology companies. Mr. Narachi received a B.S. in Biology and an M.A. degree in Biology and Genetics from the University of California at Davis. He received an M.B.A. from the Anderson Graduate School of Management at University of California, Los Angeles. Mr. Narachi also currently serves as the Chair of the Emerging Companies Section Governing Board of BIO, the Biotechnology Industry Organization, and a member of the Board of Directors of PhRMA, the Pharmaceutical Research and Manufacturers of America.

Thomas Cannell
Thomas Cannell

Senior Management Team

Thomas Cannell
EVP, Chief Commercial Officer

Thomas R. Cannell joins Orexigen after 27 years at Merck where he held a variety of senior leadership roles. He brings strong experience in global commercialization, consumer marketing, and sales operations and management. Recent assignments have included President of Merck Canada and Head of Marketing and Strategy for MSD Japan. Earlier he served in general manager roles for a U.S. sales division and as leader of a Merck business unit, managing a multi-billion dollar product portfolio and thousands of employees. He has strong consumer experience, having served as General Manager, New Commercial Model, U.S., where he designed and successfully piloted an innovative customer centric commercial model for Merck's U.S. business. Cannell holds a Doctor of Veterinary Medicine degree from Washington State University. He has also served in the U.S. Army Reserves (currently inactive) since 1987.

Thomas Lynch
Thomas Lynch

Senior Management Team

Thomas Lynch
EVP, General Counsel & Secretary

Thomas Lynch is a veteran legal professional with more than a decade of experience in the life sciences industry as well as six years of general corporate practice. He is responsible for the company’s global legal affairs and compliance operations. Tom joined Orexigen from Novartis where, since 2012, he served as senior legal counsel in two divisions, including leading global legal and compliance support for Novartis Pharma’s neuroscience franchise and advising on business development and alliance management with partners in Europe, Japan and the U.S. Earlier, Lynch spent almost ten years with Boston Scientific in a variety of legal roles and nearly six years practicing corporate law at Dorsey & Whitney LLP. He holds a juris doctorate degree from Boston College Law School, a master’s degree in teaching from the University of St. Thomas, and a bachelor’s degree in history from Stanford University.

Heather Ace
Heather Ace

Senior Management Team

Heather Ace
EVP, Global Human Resources

Heather Ace leads the human resources organization, including talent and performance management, organizational and leadership development, compensation & benefits, and employee relations. She has held a variety of high-level executive positions overseeing human resources, communications, facilities, mergers and acquisitions and transformational change initiatives during a ten-year career in the life sciences and medical devices industries. Heather joined Orexigen from Philips HealthTech where she served as Integration Leader at and led the integration of the $1.2 billion acquisition of Volcano Corporation by Royal Philips to form a new Image-Guided Therapy business, combining industry leading interventional systems and solutions with therapy guidance tools. Prior to that role, she served as the EVP, Global Human Resources at Volcano Corporation and VP, Human Resources at Life Technologies in various positions of responsibility serving key business units, functions, the Europe, Middle East and Africa regions and numerous M&A transactions. She earned her bachelor’s degree in Law & Society from the University of California, Santa Barbara, and a juris doctorate degree from Santa Clara School of Law, cum laude.

Senior Management